GLIOMAS
Clinical trials for GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new GLIOMAS trials appear
Sign up with your email to follow new studies for GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug shows promise for Hard-to-Treat brain tumors
Disease control CompletedThis study tested the drug nivolumab in 35 adults with a type of brain tumor (glioma) that has an IDH mutation and came back after previous treatment. The goal was to see if the drug could shrink the tumors. Nivolumab is an immunotherapy that helps the immune system fight cancer,…
Matched conditions: GLIOMAS
Phase: PHASE2 • Sponsor: Fabio Iwamoto, MD • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
450 brain tumor patients reveal key survival clues
Knowledge-focused CompletedThis study looked back at 450 people who had surgery for a type of brain tumor called cerebellar glioma. Researchers wanted to see if where the tumor was located and its genetic makeup could predict how well surgery worked and how long patients lived. The goal was to find better …
Matched conditions: GLIOMAS
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC